Quaker Chemical Corporation (KWR)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$161.50+0.73%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · KWR
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within materials on a research-validated quality screen. As of 2026-09-04.
The screen ranks KWR against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on driving revenue growth by winning new business across all segments and gaining market share despite soft end markets.
Stated as a priority in 4 of last 4 quarters. Revenue grew from $442.9M in 2026-Q1 to $532.6M in 2026-Q2, a 10% increase year-over-year, driven by new business wins and share gains across all segments. Management consistently emphasized new business wins as the driver of volume growth, and the trajectory is delivering with sustained revenue growth.
“Net sales increased 10% driven by new business wins across all segments.”
“Organic sales volumes increased 3% Y/Y driven by new business wins of approximately 4%.”
“Net share gains globally were approximately 4%, offsetting weak underlying market conditions.”
“Volume growth reflected new business wins across all regions that exceeded the high end of our target range.”
Continue disciplined cost control and pricing initiatives to offset raw material inflation and stabilize gross margins within target range.
Stated in 3 of last 3 quarters. Non-GAAP gross margin was 35.5% in 2026-Q2, slightly below 36.0% in 2025-Q2, reflecting raw material inflation. Management's pricing and cost initiatives have aimed to stabilize margins, and the trajectory shows margin stability with some pressure but on track to meet targets.
“Pricing and cost initiatives have kept us on track to exit the year within our target gross margin range.”
“Implemented price recovery and cost actions to mitigate raw material inflation impact.”
“Gross margins were flat to prior year, expected to improve in Q1 2026 as operational issues resolved.”
Focus on generating positive operating cash flow and maintaining liquidity through amended credit agreements and disciplined working capital management.
Stated in 3 disclosures including 2 quarters and a credit agreement announcement. Operating cash flow was $3.8M in 2026-Q1 and $33.2M for six months ended 2026-Q2, showing improvement year-over-year. The amended credit agreement extends maturities to 2031 and increases credit availability, supporting liquidity. The trajectory shows progress in cash flow generation and balance sheet strengthening.
“Net cash provided by operating activities was $33.2 million for six months ended June 30, 2026.”
“Net cash provided by operating activities was $3.8 million for three months ended March 31, 2026.”
Implement a global transformation program targeting $20 to $30 million in annualized cost savings by 2028 with a $10 million run rate by end of 2026.
Stated in 2 quarters including 2026-Q1. The company targets $20 to $30 million in annualized cost savings by 2028 with a $10 million run rate by end of 2026. Restructuring charges have been recorded in prior periods. The trajectory shows initiation of the program with expected ramp-up in savings.
“New global transformation and cost program targeting $20 to $30 million savings by 2028.”
“Restructuring and related charges, net included in operating income adjustments.”
Maintain dividend payments and execute share repurchase programs to return capital to shareholders.
Stated in 3 quarters including 2026-Q2. The company repurchased $24.2M of shares and increased the quarterly dividend by 4.3% in Q2 2026. Prior quarters show consistent share repurchases and dividend payments. The trajectory shows ongoing capital return to shareholders.
“Repurchased $24.2 million of shares and increased quarterly dividend by approximately 4.3%.”
“Repurchased 38,893 shares for approximately $5.0 million in Q4 2025.”
“In 2025, repurchased 364,797 shares for approximately $41.5 million.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Materials names rated strong grew net income 61% of the time over the next year (vs 47% for the rest of the cohort, n=1943).
Over the trailing year it converted 1.22x of net income into operating cash flow. Historically, Materials names rated neutral grew net income 49% of the time over the next year (vs 50% for the rest of the cohort, n=1862).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to real (inflation-adjusted) rates, long-term interest rates, the US dollar, Fed net liquidity (low R² over the window).
12 material management or governance events in the past 24 months, led by executive changes. Historically, Materials names rated neutral grew net income 49% of the time over the next year (vs 52% for the rest of the cohort, n=976).
Not investment advice. As of 2026-09-04.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.